L

Lucid Diagnostics
D

LUCD

1.00000
USD
0.01
(1.01%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-1
Market Cap
55,445,039
News

Title: Lucid Diagnostics

Sector: Healthcare
Industry: Medical Devices
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.